MT Medicals developed a highly specific inhibitor of cytochrome P450 enzymes that demonstrates high conservation.
Business Model:
Revenue: $0
Employees: 11-50
Address:
City: Hefei
State: Anhui
Zip:
Country: China
MT-Medicals developed a highly specific inhibitor of cytochrome P450 enzymes that demonstrate high conservation, which greatly reduces the probability of tuberculosis bacterial resistance to the new treatment. Its use significantly optimizes the existing combined treatment regimens for resistant forms of tuberculosis and supports the individualization of such treatment. MT-Medicals is based in Hefei City, Anhui Province, China.
Contact Phone:
Contact Email:
Announced Date | Company | Transaction | Money Raised |
---|
Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 10/2017 | Venture Round | 1 | - |
Primer Capital Primer Capital |
10/2017 | Venture Round | 1 | - |
Primer Capital Primer Capital |
---|
Announced Date | Name | Price |
---|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|